CORONA Remedies Limited (CORONA) — share transfer | 6 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

CORONA Remedies Limited received a SEBI-mandated certificate confirming Regulation 74(5) does not apply to its shares for Q1 ending June 30, 2026, as all shares remain fully dematerialized with no rematerialization requests received during the quarter.

📄 View Original Announcement (PDF)

About CORONA Remedies Limited (CORONA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹10,869.98 Cr

View full CORONA stock details →

📡 Get AI alerts when CORONA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CORONA — Free

📊 More CORONA filings

See all CORONA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CORONA files new disclosures

Track CORONA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CORONA — Free

Free account · 2 AI queries/day